Opendata, web and dolomites

BILISTICK

BILISTICK: A low cost point-of-care for early diagnosis of hyperbilirubinemia in newborns

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 BILISTICK project word cloud

Explore the words cloud of the BILISTICK project. It provides you a very rough idea of what is the project "BILISTICK" about.

newborns    disease    diagnosis    off    national    competitors    care    point    promptly    purpose    acceptance    discharge    severe    mainly    thousands    invasive    device    dis    feasibility    permanent    of    healthcare    university    nature    academic    aap    minimally    professional    preventable    examination    spin    recommend    rapid    diagnostic    giving    emphasis    kernicterus    put    consequence    medical    universal    expensive    biomarkers    innovative    viewpoint    largely    measuring    core    blood    team    oriented    bilistick    post    guidelines    damage    accurate    functions    company    union    business    worst    vitro    solutions    bilirubin    economical    consequent    screening    prevent    international    bilimetrix    entrepreneurial    applicable    acquired    trieste    plan    portable    solution    liver    pricing    huge    individualized    market    follow    hyperbilirubinemia    kidney    converging    heart    marketing    neurological    technologies   

Project "BILISTICK" data sheet

The following table provides information about the project.

Coordinator
BILIMETRIX SRL 

Organization address
address: AREA SCIENCE PARK ED Q
city: TRIESTE
postcode: 34149
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Italy [IT]
 Project website http://www.bilimetrix.net
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2015
 Funding Scheme SME-1
 Starting year 2016
 Duration (year-month-day) from 2016-02-01   to  2016-07-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    BILIMETRIX SRL IT (TRIESTE) coordinator 50˙000.00

Map

 Project objective

The objective of the overall project is to lead to the international market “Bilistick”, an innovative low-cost Point-of-Care for early diagnosis of hyperbilirubinemia. The system aims to prevent, through early diagnosis, the permanent neurological damage that severe hyperbilirubinemia can cause in newborns.Every year in European Union there are about 3 thousands cases of kernicterus (worst consequence of hyperbilirubinemia) determining consequent huge costs for National Healthcare Systems. Kernicterus is a largely preventable disease if severe hyperbilirubinemia is identified early and promptly treated. For this reason AAP Guidelines (adopted by EU) recommend universal bilirubin screening and individualized post-discharge follow-up care based on results of such screening. However existing solutions are expensive, not portable or not enough accurate. Bilistick is the only in vitro rapid diagnostic device for measuring the level of bilirubin in the blood of newborns. It is low cost, minimally invasive, portable, giving rapid response, accurate and applicable in all newborns. It is the result of experience acquired during years of academic and professional research carried out by the entrepreneurial team of Bilimetrix s.r.l.. Bilimetrix s.r.l. is a spin-off of the University of Trieste, established as a research and development company. Its core business is development of medical devices based on advanced technologies oriented on liver, kidney and heart dis-functions. All solution are mainly based on new biomarkers. The purpose of the feasibility study is a comprehensive examination of all aspects of feasibility of the project, from the technical to the economical viewpoint, converging in a detailed business plan for application in Phase 2. Emphasis will be put on market analysis (nature of the market, type of users, competitors in the market, pricing systems, methods of distribution and marketing) and then on examination of the market acceptance towards Bilistick

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "BILISTICK" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "BILISTICK" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

PREFERABLE (2019)

Project on Exercise for Fatigue Eradication in Advanced Breast cancer to improve quality of life

Read More  

TT4CL (2019)

Clinical development of oral oleylphosphocholine as a new drug for the treatment of Old World Cutaneous Leishmaniasis

Read More  

MISTRAL (2020)

Microbiome-based stratification of individuals at risk of HIV-1 acquisition, chronic clinical complications,antimicrobial drug resistance,and unresponsiveness to therapeutic HIV-1 vaccination

Read More